Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 11-Feb-04 10:00 PM View:  | Manchester Keith S VP, BUSINESS DEVELOPMENT | Applied Molecular Evolution... (AMEV) | 09-Feb-04 | Acquisition (other) | 1,885 | $1.74 | $3,279.90 | < 1% 341.32K to 343.21K | |
| 11-Feb-04 10:00 PM View: | Manchester Keith S VP, BUSINESS DEVELOPMENT | Applied Molecular Evolution... (AMEV) | 09-Feb-04 | Exercise (in-the money or at-the-money) | 28,328 | $7.23 | $204,701.00 | 8% 343.21K to 371.54K | |
| 11-Feb-04 10:00 PM View: | Bloch Lawrence E CFO, SECRETARY | Applied Molecular Evolution... (AMEV) | 09-Feb-04 | Acquisition (other) | 881 | $1.74 | $1,532.94 | < 1% 815.75K to 816.63K | |
| 11-Feb-04 10:00 PM View: | Breitmeyer James B VP PHARMACEUTICAL OPERATIONS | Applied Molecular Evolution... (AMEV) | 09-Feb-04 | Acquisition (other) | 4,907 | $1.74 | $8,538.18 | 17% 28.27K to 33.17K | |
| 11-Feb-04 10:00 PM View: | Watkins Jeffry D CHIEF SCIENTIFIC OFFICER | Applied Molecular Evolution... (AMEV) | 09-Feb-04 | Acquisition (other) | 607 | $1.74 | $1,056.18 | < 1% 340.44K to 341.04K | |
| 11-Feb-04 10:00 PM View: | Bloch Lawrence E CFO, SECRETARY | Applied Molecular Evolution... (AMEV) | 09-Feb-04 | Exercise (in-the money or at-the-money) | 329 | $5.82 | $1,914.85 | < 1% 816.63K to 816.96K | |
| 05-Feb-04 10:00 PM View: | Dittamore Raymond V Director | Applied Molecular Evolution... (AMEV) | 03-Feb-04 | Exercise (in-the money or at-the-money) | 9,000 | $4.60 | $41,400.00 | 100% 0 to 9.0K | |
| 05-Feb-04 10:00 PM View: | Bloch Lawrence E CFO, SECRETARY | Applied Molecular Evolution... (AMEV) | 03-Feb-04 | Exercise (in-the money or at-the-money) | 29,092 | $7.07 | $205,548.00 | 4% 786.65K to 815.75K | |
| 12-Jan-04 10:00 PM View: | Bvf Partners L P/il 10% Owner | Applied Molecular Evolution... (AMEV) | 08-Jan-04 | Sale | 822,900 | $17.80 | $14,648,200.00 | (53%) 1.54M to 721.19K | |
| 08-Jan-04 10:00 PM View: | Bvf Partners L P/il 10% Owner | Applied Molecular Evolution... (AMEV) | 06-Jan-04 | Sale | 94,900 | $17.79 | $1,687,980.00 | (8%) 1.21M to 1.12M | |
| 06-Jan-04 10:00 PM View: | Bvf Partners L P/il 10% Owner | Applied Molecular Evolution... (AMEV) | 05-Jan-04 | Sale | 190,000 | $17.79 | $3,380,100.00 | (14%) 1.36M to 1.17M | |
| 05-Jan-04 10:00 PM View: | Bloch Lawrence E CFO, SECRETARY | Applied Molecular Evolution... (AMEV) | 02-Jan-04 | Acquisition (other) | 11,314 | $1.74 | $19,686.40 | 1% 775.34K to 786.65K | |
| 05-Jan-04 10:00 PM View: | Watkins Jeffry D CHIEF SCIENTIFIC OFFICER | Applied Molecular Evolution... (AMEV) | 02-Jan-04 | Acquisition (other) | 755 | $1.74 | $1,313.70 | < 1% 339.68K to 340.44K | |
| 05-Jan-04 10:00 PM View: | Breitmeyer James B VP PHARMACEUTICAL OPERATIONS | Applied Molecular Evolution... (AMEV) | 02-Jan-04 | Acquisition (other) | 6,264 | $1.74 | $10,899.40 | 28% 22.0K to 28.27K | |
| 06-Jan-04 10:00 PM View: | Bvf Partners L P/il 10% Owner | Applied Molecular Evolution... (AMEV) | 02-Jan-04 | Sale | 475,000 | $17.80 | $8,455,000.00 | (27%) 1.73M to 1.26M | |
| 05-Jan-04 10:00 PM View: | Manchester Keith S VP, BUSINESS DEVELOPMENT | Applied Molecular Evolution... (AMEV) | 02-Jan-04 | Acquisition (other) | 10,310 | $1.74 | $17,939.40 | 3% 331.01K to 341.32K | |
| 23-Sep-03 10:00 PM View: | Breitmeyer James B CHIEF MEDICAL OFFICER | Applied Molecular Evolution... (AMEV) | 19-Sep-03 | Exercise (in-the money or at-the-money) | 7,440 | $2.45 | $18,228.00 | 51% 14.56K to 22.0K |
